|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0013216,
umls-concept:C0032529,
umls-concept:C0205179,
umls-concept:C0205210,
umls-concept:C0268138,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1333356,
umls-concept:C1366475,
umls-concept:C1514162,
umls-concept:C1704632,
umls-concept:C1705972,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-7-31
|
|
pubmed:abstractText |
DNA repair system plays an important role in tumor sensitivity to platinum-based chemotherapy. The purpose of this study was to examine the association between polymorphisms in XRCC1 and XPD, which are involved in DNA repair, and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC).
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0253-3766
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
196-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16875604-Adult,
pubmed-meshheading:16875604-Aged,
pubmed-meshheading:16875604-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16875604-Carboplatin,
pubmed-meshheading:16875604-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16875604-Cisplatin,
pubmed-meshheading:16875604-DNA Repair,
pubmed-meshheading:16875604-DNA-Binding Proteins,
pubmed-meshheading:16875604-Female,
pubmed-meshheading:16875604-Genotype,
pubmed-meshheading:16875604-Humans,
pubmed-meshheading:16875604-Lung Neoplasms,
pubmed-meshheading:16875604-Male,
pubmed-meshheading:16875604-Middle Aged,
pubmed-meshheading:16875604-Paclitaxel,
pubmed-meshheading:16875604-Polymorphism, Genetic,
pubmed-meshheading:16875604-Remission Induction,
pubmed-meshheading:16875604-Vinblastine,
pubmed-meshheading:16875604-Xeroderma Pigmentosum Group D Protein
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
[XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].
|
|
pubmed:affiliation |
Department of Medical Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
